Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 3
2006 2
2007 5
2008 6
2009 4
2010 6
2011 2
2012 5
2013 5
2014 3
2015 7
2016 6
2017 4
2018 3
2019 1
2020 9
2021 7
2022 4
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Musella M, Guarracino A, Manduca N, Galassi C, Ruggiero E, Potenza A, Maccafeo E, Manic G, Mattiello L, Soliman Abdel Rehim S, Signore M, Pietrosanto M, Helmer-Citterich M, Pallocca M, Fanciulli M, Bruno T, De Nicola F, Corleone G, Di Benedetto A, Ercolani C, Pescarmona E, Pizzuti L, Guidi F, Sperati F, Vitale S, Macchia D, Spada M, Schiavoni G, Mattei F, De Ninno A, Businaro L, Lucarini V, Bracci L, Aricò E, Ziccheddu G, Facchiano F, Rossi S, Sanchez M, Boe A, Biffoni M, De Maria R, Vitale I, Sistigu A. Musella M, et al. Among authors: biffoni m. Nat Immunol. 2022 Sep;23(9):1379-1392. doi: 10.1038/s41590-022-01290-3. Epub 2022 Aug 24. Nat Immunol. 2022. PMID: 36002648 Free PMC article.
MiR126-targeted-nanoparticles combined with PI3K/AKT inhibitor as a new strategy to overcome melanoma resistance.
Arasi MB, De Luca G, Chronopoulou L, Pedini F, Petrucci E, Flego M, Stringaro A, Colone M, Pasquini L, Spada M, Lulli V, Perrotta MC, Calin GA, Palocci C, Biffoni M, Felicetti F, Felli N. Arasi MB, et al. Among authors: biffoni m. Mol Ther. 2024 Jan 3;32(1):152-167. doi: 10.1016/j.ymthe.2023.11.021. Epub 2023 Nov 21. Mol Ther. 2024. PMID: 37990493 Free article.
NextGEM: Next-Generation Integrated Sensing and Analytical System for Monitoring and Assessing Radiofrequency Electromagnetic Field Exposure and Health.
Petroulakis N, Mattsson MO, Chatziadam P, Simko M, Gavrielides A, Yiorkas AM, Zeni O, Scarfi MR, Soudah E, Otin R, Schettino F, Migliore MD, Miaoudakis A, Spanoudakis G, Bolte J, Korkmaz E, Theodorou V, Zarogianni E, Lagorio S, Biffoni M, Schiavoni A, Boldi MR, Feldman Y, Bilik I, Laromaine A, Gich M, Spirito M, Ledent M, Segers S, Vargas F, Colussi L, Pruppers M, Baaken D, Bogdanova A. Petroulakis N, et al. Among authors: biffoni m. Int J Environ Res Public Health. 2023 Jun 8;20(12):6085. doi: 10.3390/ijerph20126085. Int J Environ Res Public Health. 2023. PMID: 37372672 Free PMC article.
CD8+CD103+PD1+TIM3+ T cells in glioblastoma microenvironment correlate with prognosis.
Romagnoli G, D'Alessandris QG, Capone I, Tavilla A, Canini I, Lapenta C, Buccarelli M, Giordano M, Tirelli V, Sanchez M, Fragale A, Giannetti S, Di Bonaventura R, Lauretti L, Biffoni M, Ricci-Vitiani L, Pallini R, Gabriele L. Romagnoli G, et al. Among authors: biffoni m. Immunology. 2024 Feb;171(2):198-211. doi: 10.1111/imm.13710. Epub 2023 Oct 26. Immunology. 2024. PMID: 37884280
New models for cancer research: human cancer stem cell xenografts.
Baiocchi M, Biffoni M, Ricci-Vitiani L, Pilozzi E, De Maria R. Baiocchi M, et al. Among authors: biffoni m. Curr Opin Pharmacol. 2010 Aug;10(4):380-4. doi: 10.1016/j.coph.2010.05.002. Epub 2010 Jun 17. Curr Opin Pharmacol. 2010. PMID: 20561817 Review.
An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile.
De Angelis ML, Francescangeli F, Nicolazzo C, Signore M, Giuliani A, Colace L, Boe A, Magri V, Baiocchi M, Ciardi A, Scarola F, Spada M, La Torre F, Gazzaniga P, Biffoni M, De Maria R, Zeuner A. De Angelis ML, et al. Among authors: biffoni m. J Exp Clin Cancer Res. 2022 Mar 8;41(1):86. doi: 10.1186/s13046-022-02263-y. J Exp Clin Cancer Res. 2022. PMID: 35260172 Free PMC article.
L1077P CFTR pathogenic variant function rescue by Elexacaftor-Tezacaftor-Ivacaftor in cystic fibrosis patient-derived air-liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients.
Lo Cicero S, Castelli G, Blaconà G, Bruno SM, Sette G, Pigliucci R, Villella VR, Esposito S, Zollo I, Spadaro F, Maria R, Biffoni M, Cimino G, Amato F, Lucarelli M, Eramo A. Lo Cicero S, et al. Among authors: biffoni m. Respir Res. 2023 Sep 6;24(1):217. doi: 10.1186/s12931-023-02516-0. Respir Res. 2023. PMID: 37674160 Free PMC article.
Agile workflow for interactive analysis of mass cytometry data.
Casado J, Lehtonen O, Rantanen V, Kaipio K, Pasquini L, Häkkinen A, Petrucci E, Hynninen J, Hietanen S, Carpén O, Biffoni M, Färkkilä A, Hautaniemi S. Casado J, et al. Among authors: biffoni m. Bioinformatics. 2021 Jun 9;37(9):1263-1268. doi: 10.1093/bioinformatics/btaa946. Bioinformatics. 2021. PMID: 33135052 Free PMC article.
84 results